title: Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.
abstract: A telematic system supporting intensive insulin treatment of pregnant type 1 diabetic out-clinic patients was implemented and technical efficiency of the system was evaluated over long-term ambulatory application. The system consists of a patient teletransmission module (PTM) and a central clinical control unit (CCU). The PTM contains a one-box blood glucose meter and electronic logbook, a modem and a dial-up or cellular phone set. The CCU consists of a PC computer with a modem and DIAPRET - an original program designed to monitor the intensive insulin treatment. The system was installed in the Clinic of Gastroenterology and Metabolic Disease, MA Warsaw and was tested for 166 +/- 24 days on 15 pregnant type 1 diabetic women. Telemonitoring of the patient data was done automatically. No major technical problems with proper operation or handling of the system was noted. Total effectiveness was 69.3 +/- 13.0% and technical effectiveness 91.5 +/- 6.1%. The efficacy of the system was not significantly influenced by patient intelligence level, education level or place of residence (p < 0.05). Significant improvement of metabolic control was noted during application of the system. In conclusion, the telematic system we developed and implemented should have a positive influence on the quality of diabetes treatment during pregnancy.
authors: Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw - Poland. Piotr.Ladyzynski@ibib.waw.pl
authors: P
authors: P
authors: Ladyzyński
authors: J M
authors: JM
authors: Wójcicki
authors: J
authors: J
authors: Krzymień
authors: J
authors: J
authors: Blachowicz
authors: E
authors: E
authors: Jóźwicka
authors: K
authors: K
authors: Czajkowski
authors: E
authors: E
authors: Janczewska
authors: W
authors: W
authors: Karnafel
mesh_terms: D000328:Adult; D000465:Algorithms; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D012984:Software; D017216:Telemedicine; D016896:Treatment Outcome; D014584:User-Computer Interface
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin